MMP9 and substance withdrawal syndrome: YKS, acting via the inhibition of MMP-9, might provide a new candidate for the prevention and treatment of cancer pain as well as reduce opioid-induced unwanted side effects (such as opioid-induced hyperalgesia, dependence, tolerance, and withdrawal syndrome).